Vaccine Immunotherapies in Prostate Cancer
CME Monograph - September 2005
This educational monograph was developed for urologists and oncologists who treat patients with prostate cancer by Martin G. Sanda, MD, Beth Israel Deaconess Medical Center; Robert S. DiPaola, MD, The Cancer Institute of New Jersey; Charles G. Drake, MD, PhD, Johns Hopkins Medical Center; Jonathan Simons, MD, Emory University and Johannes Vieweg, MD, Duke University Medical Center.
The educational objectives for this enduring CME activity are to discuss the fundamentals of tumor immunology relevant to prostate cancer; describe the technology and mechanism of action for poxviruses as vaccines, tumor cell vaccines and dendritic cell vaccines; discuss the current clinical results for poxviruses as vaccines, tumor cell vaccines and dendritic cell vaccines and assess the potential for using each of the above immunotherapeutics in prostate cancer treatment. The program was supported by educational grants from industry. Program management and CME sponsorship were provided by InforMEDical.
